Tumor markers

Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...

Scotland

With the United Kingdom, Scotland represents a long-standing center of biotechnological excellence, ranked in the top 5 in the world. Over the years, the following important developments have occurr...

Metabolic fingerprinting: Using proteomics to identify proteins in gymnosperm pollination drops

(American Journal of Botany) Proteomics is a powerful technique for examining the structure and function of the proteome. Proteomics can uncover the relationship between DNA, RNA, and the production o...

Unlabeled proteomics: Sidebar: Activiomics Ltd. Corporate Profile

Activiomics: Unlabeled proteomics Activiomics Ltd. London, U.K. Technology: TIQUAS label-free proteomics technology Disease focus: Cancer, inflammation, metabolic Clinical status: Discovery Founded: 2...

BC Proteomics Network receives renewed funding from MSFHR

The BC Proteomics Network has received renewed funding from the Michael Smith Foundation for Health Research (MSFHR) totaling $1.6 million over a five year term. The second phase of MSFHR funding will...

Tecan microarray solutions transform functional proteomics workflows at ASU

“We have adopted a unique approach to functional proteomics..."

Potential Blood Biomarkers for Stroke

Technological advances in proteomics have permitted a more effective search for novel biomarkers in stroke. What are the latest -- and most promising -- biomarker candidates? Expert Review of Proteo...

Bruker and the Genome British Columbia Proteomics Centre at the University of Victoria Announce Collaboration on Development of High Throughput iMALDI Assays

Bruker and the University of Victoria-Genome British Columbia Proteomics Centre (UVic GBC Proteomics Centre) have announced a collaborative effort for the development and validati...

A large synthetic peptide and phosphopeptide reference library for mass spectrometry–based proteomics

Mass spectra for >100,000 synthetic peptides provide a basis for improving proteomics experiments and analysis algorithms.

The new age of proteomics: An integrative vision of the cellular world

(Centro Nacional de Investigaciones Oncologicas (CNIO)) The head of CNIO's Proteomics Core Unit, Javier Muñoz, working alongside Dutch researchers, revises the technology of the post-­‐ge...

Two-dimensional gel electrophoresis in proteomics: past, present and future.

Two-dimensional gel electrophoresis has been instrumental in the birth and developments of proteomics, although it is no longer the exclusive separation tool used in the field of proteomics. In this r...

Viewpoints in Clinical Proteomics - when will proteomics deliver clinically useful information?

Proteomics has not delivered biomarkers of clinical value, despite massive efforts. The technologies that are emerging today have, however, the power to reach deep into proteomes and to identify patte...

Facing challenges in Proteomics today and in the coming decade: Report of Roundtable Discussions at the 4th EuPA Scientific Meeting, Portugal, Estoril 2010.

Pediatric proteomics: an introduction.

The overall goal of this series is to detail the paradigm shift that proteomics will bring to the practice of pediatric medicine and research. Proteomics is the global study of proteins in a biologica...

Translational plant proteomics: A perspective.

Translational proteomics is an emerging sub-discipline of the proteomics field in the biological sciences. Translational plant proteomics aims to integrate knowledge from basic sciences to translate i...